Regulatory PathRegulatory requirements compared

Active substance

Cefadroxil

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CEFADROX 250MG-5ML SUSPENSION50 mg/mlSuspension · Oral use1 BottleSAR 22.15Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
CEFADROX 500MG CAPSULE500 mgCapsule · Oral use12 BlisterSAR 30.55Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
CEFADROX 500MG-5ML SUSPENSION100 mg/mlSuspension · Oral use1 BottleSAR 44.55Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
MIDROXIL 250MG\5ML SUSP50 mg/mlOral suspension · Oral use1 BottleSAR 12.85Generic · PrescriptionMiddle East Pharmaceutical and Chemical Industries and Medical Appliances Co.Valid
MIDROXIL 500 MG CAPSULE500 mgCapsule · Oral use12 BlisterSAR 19.25Generic · PrescriptionMiddle East Pharmaceutical and Chemical Industries and Medical Appliances Co.Valid
MIDROXIL 500MG\5ML SUSP.100 mg/mlOral suspension · Oral use1 BottleSAR 20.40Generic · PrescriptionMiddle East Pharmaceutical and Chemical Industries and Medical Appliances Co.Valid
ROXIL 250MG-5ML SUSP.50 mg/mlPowder for oral suspension · Oral use1 BottleSAR 24.60Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
ROXIL 500MG CAPS500 mgCapsule, hard · Oral use20 BlisterSAR 56.60Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
BIODROXIL 1 GM FILM COATED1 gFilm-coated tablet · Oral use12 BlisterSAR 47.25Generic · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
BIODROXIL 125MG\5ML25 mg/mlSuspension · Oral use1 BottleSAR 14.55Generic · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
BIODROXIL 250MG\5ML50 mg/mlSuspension · Oral use1 BottleSAR 24.40Generic · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
BIODROXIL 500MG-5ML SUSPENSION100 mg/mlSuspension · Oral use1 BottleSAR 47.95Generic · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
BIODROXIL500MG CAP500 mgCapsule · Oral use20 BlisterSAR 49.35Generic · PrescriptionSANDOZWithdrawn by MAH · Not Marketed
CEFADRIL 250MG\5ML SUSPENSION50 mg/mlSuspension · Oral use1 BottleSAR 10.35Generic · PrescriptionRam Pharmaceutical IndustriesWithdrawn by MAH · Not Marketed
CEFADRIL 500 MG CAPSULES500 mgCapsule · Oral use12 BlisterSAR 17.35Generic · PrescriptionRam Pharmaceutical IndustriesWithdrawn by MAH · Not Marketed
ULTRACEF 250MG PWD.FOR SUSP50 mg/mlPowder for suspension · Oral use1 BottleSAR 27.90NCE · PrescriptionBRISTOL-MYERS COInvalid · Not Marketed
ULTRACEF 500MG CAPS500 mgCapsule · Oral use20 BlisterSAR 62.90NCE · PrescriptionBRISTOL-MYERS SQUIBBWithdrawn by MAH · Not Marketed
ULTRACEF 500MG-5ML SUSP100 mg/mlSuspension · Oral use1 BottleSAR 49.50NCE · PrescriptionBRISTOL-MYERS COInvalid · Not Marketed
Indications — CHI Daman Drug Formulary

ACUTE PYELONEPHRITIS; BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION; INTRA-ABDOMINAL INFECTIONS; LOWER URINARY TRACT INFECTIONS; OSTEOMYELITIS; PHARYNGITIS

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO-CEFADROXIL02240774500 MGCAPSULE · ORALAPOTEX INC
JAMP CEFADROXIL02544792500 MGCAPSULE · ORALJAMP PHARMA CORPORATION
TEVA-CEFADROXIL02235134500 MGCAPSULE · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCEFADROXIL 1 GM TABLET$3.37367per EA23 Sep 2026
US NADACCEFADROXIL 250 MG/5 ML SUSP$0.16745per ML23 Sep 2026
US NADACCEFADROXIL 500 MG CAPSULE$0.26904per EA23 Sep 2026
US NADACCEFADROXIL 500 MG/5 ML SUSP$0.26533per ML23 Sep 2026
US NADACCEFADROXIL 500 MG/5 ML SUSP$0.22431per ML23 Sep 2026
NHS Drug TariffCefadroxil 500mg capsules£22.3820 capsule1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.